On this week’s Tech Nation, Moira speaks with Dr. Greg Frost, the CEO of Exuma Biotech. He explains how gene therapy for cancer is currently a 6 to 8 week proposition, and requires the patient to undergo chemotherapy. Exuma’s aim is to reduce the time to 4 hours and eliminate the chemotherapy …
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.
Then Dr. Chris Smith with Brandon Capital Partners and a board member of Ena Respiratory talks about updates us on Ena-51 – a spray to reduce the presence of COVID in the nasal passageway.
Fler avsnitt av TechNation Radio Podcast
Visa alla avsnitt av TechNation Radio PodcastTechNation Radio Podcast med Tech Nation finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
